CoreX | Sovereign Bio-Intelligence
Rewriting the future of pharma from the world’s most visionary nation.
CoreX is the UAE’s sovereign biotech platform — building the world’s first end-to-end AI-powered drug development engine. Powered by organoid avatars, IPSC technology, and a proprietary BioLLM trained on real biology, CoreX is replacing outdated clinical trials with predictive, population-aware science.
From molecule discovery to pharmacoequity validation, CoreX integrates:
• Biological AI that learns from patient-derived organoids.
• A Population Library that ensures every drug is tested across real-world demographics.
• A new Pharma Sovereignty Model where nations lead innovation, data ownership, and regulatory validation.
Backed by Quris and born in Abu Dhabi, CoreX partners with governments, pharma, and investors to:
• Accelerate safer, personalized, and inclusive drug development
• Monetize data and biological IP at national scale
• Create new revenue models from generics, repurposed drugs, and platform licensing
Built by and for sovereign health systems.
Designed to serve 8 billion.
Company Details
- Employees
- 1
- Founded
- -
- Industry
- Health And Human Services
- NAICS
-
Administration of Human Resource ProgramsAdministration of Veterans' Affairs
- Competitors
- FutureMed Innovation, FutureMed, LifeX.
Corex Abu Dhabi Questions
Corex Abu Dhabi's LinkedIn profile is https://www.linkedin.com/company/corexabudhabi
Corex Abu Dhabi has
1 employees.
View email and phone details for 1
employees at Corex Abu Dhabi.
Corex Abu Dhabi's industry is
Health and Human Services
Corex Abu Dhabi's categories are Health and Human Services
Corex Abu Dhabi's founding year is 2025
